FDA Inspection 1090255 — Biotest Pharmaceuticals Corporation
The FDA completed an inspection of Biotest Pharmaceuticals Corporation on March 28, 2019 in Valdosta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 28, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Valdosta, GA (United States)